Senzar Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-29,821
| Closed | -$502K | – | 18 |
|
|
2018
Q2 | $502K | Sell |
29,821
-169,318
| -85% | -$2.85M | 1.45% | 18 |
|
|
2018
Q1 | $4.56M | Sell |
199,139
-77,206
| -28% | -$1.77M | 1.44% | 26 |
|
|
2017
Q4 | $7.15M | Sell |
276,345
-59,100
| -18% | -$1.53M | 1.83% | 21 |
|
|
2017
Q3 | $4.95M | Sell |
335,445
-76,700
| -19% | -$1.13M | 1.21% | 21 |
|
|
2017
Q2 | $5.75M | Sell |
412,145
-4,700
| -1% | -$65.6K | 1.42% | 18 |
|
|
2017
Q1 | $7.11M | Buy |
416,845
+16,257
| +4% | +$277K | 1.8% | 20 |
|
|
2016
Q4 | $4.12M | Sell |
400,588
-171,800
| -30% | -$1.77M | 1.09% | 22 |
|
|
2016
Q3 | $5.79M | Sell |
572,388
-228,400
| -29% | -$2.31M | 1.5% | 22 |
|
|
2016
Q2 | $8.99M | Sell |
800,788
-670,905
| -46% | -$7.53M | 1.96% | 16 |
|
|
2016
Q1 | $20.1M | Buy |
1,471,693
+39,076
| +3% | +$534K | 3.99% | 9 |
|
|
2015
Q4 | $27.2M | Sell |
1,432,617
-213,056
| -13% | -$4.04M | 3.02% | 9 |
|
|
2015
Q3 | $30.9M | Buy |
1,645,673
+88,139
| +6% | +$1.65M | 4.49% | 6 |
|
|
2015
Q2 | $23.2M | Buy |
1,557,534
+441,434
| +40% | +$6.57M | 3.98% | 6 |
|
|
2015
Q1 | $16.9M | Buy |
1,116,100
+249,900
| +29% | +$3.78M | 4.12% | 9 |
|
|
2014
Q4 | $11.5M | Buy |
866,200
+605,000
| +232% | +$8.06M | 3.38% | 10 |
|
|
2014
Q3 | $3.29M | Buy |
+261,200
| New | +$3.29M | 0.97% | 25 |
|